Characterization of the progressive sublines derived from a weakly malignant cloned cell line, ER-1, co-inoculated subcutaneously with a foreign body

Clin Exp Metastasis. 1998 Apr;16(3):291-8. doi: 10.1023/a:1006505211766.

Abstract

We previously established an experimental model of tumor progression using a weakly malignant rat mammary carcinoma cell line, ER-1. Using this model, we demonstrated that ER-1 cells converted into highly tumorigenic and metastatic cells, ERpP, by s.c. co-inoculation with plastic plates. We here compared in vitro biological properties associated with malignancy of ER-1 cells with those of ERpP cells which were highly malignant when inoculated into syngeneic rats. In vitro growth rate of ERpP cells was higher than that of ER-1 cells under a low nutrient condition. Invasion capacity of ERpP cells to rat lung endothelial cell monolayer or reconstituted basement membrane, Matrigel, was higher than that of ER-1 cells. Migration of ERpP cells toward fibronectin or laminin was also significantly higher than that of ER-1 cells. There was no difference in gelatinolytic or plasminogen activator activity detected in conditioned media between ER-1 and ERpP cells. Furthermore, we found that ER-1 cells communicated better among themselves and with normal fibroblasts through gap junctions compared to ERpP cells. These results suggest that growth advantage in a poor nutrient condition, enhancement of cell motility, and loss or decrease of junctional communication may be associated with tumor progression of ER-1 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Communication
  • Cell Division
  • Chemotaxis
  • Collagen
  • Drug Combinations
  • Endothelium, Vascular / cytology
  • Fibronectins
  • Gelatinases / metabolism
  • Intercellular Junctions
  • Laminin
  • Mammary Neoplasms, Experimental / pathology*
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Plasminogen Activators / metabolism
  • Proteoglycans
  • Rats
  • Tumor Cells, Cultured

Substances

  • Drug Combinations
  • Fibronectins
  • Laminin
  • Proteoglycans
  • matrigel
  • Collagen
  • Plasminogen Activators
  • Gelatinases